Provided by Tiger Trade Technology Pte. Ltd.

Mangoceuticals, Inc.

1.16
+0.163816.44%
Post-market: 1.11-0.0500-4.31%17:08 EST
Volume:890.69K
Turnover:998.53K
Market Cap:16.13M
PE:-0.37
High:1.25
Open:1.01
Low:1.00
Close:0.9962
52wk High:6.15
52wk Low:0.9800
Shares:13.91M
Float Shares:7.55M
Volume Ratio:3.97
T/O Rate:11.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1399
EPS(LYR):-4.8401
ROE:-136.16%
ROA:-73.78%
PB:1.03
PE(LYR):-0.24

Loading ...

Director Alex P. Hamilton Reports Disposal of Mangoceuticals Inc. Common Shares

Reuters
·
Nov 27

U.S. Stock Movement | "Partnership Clarification" Triggers Volatility as Mangoceuticals (MGRX.US) Shares Swing Wildly

Stock News
·
Nov 14

BRIEF-Mangoceuticals Says Co Has No Direct Contractual Relationship With Eli Lilly Or Novo Nordisk

Reuters
·
Nov 14

Mangoceuticals Inc: Mangoceuticals Has No Direct Contractual Relationship With Eli Lilly or Novo Nordisk

THOMSON REUTERS
·
Nov 14

Mangoceuticals: via Mangorx Direct and Peaches Rx Direct, Co NOW Directly Offers Customers Eli Lilly and Novo Nordisk Glp-1 Medications

THOMSON REUTERS
·
Nov 14

BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APA

Reuters
·
Nov 14

Novo Nordisk, Eli Lilly Spokespeople Say the Companies Have No Affiliation With Telehealth Platform Mangoceuticals, in Response to Its Press Release on Weight-Loss Partnerships

THOMSON REUTERS
·
Nov 14

Eli Lilly, Novo Nordisk Make GLP-1 Medications Available Through Mangoceuticals Platform

MT Newswires Live
·
Nov 13

Mangoceuticals Shares up 48% Premarket After Co Partners With Eli Lilly and Novo Nordisk to Sell Weight-Loss Drugs

THOMSON REUTERS
·
Nov 13

Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs

Reuters
·
Nov 13

Mangoceuticals Partners With Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management

THOMSON REUTERS
·
Nov 13

Mangoceuticals Inc - Launches Mangorx Direct and Peachesrx Direct Programs

THOMSON REUTERS
·
Nov 13

Mangoceuticals Inc. Announces New Compensation Plan Granting CEO Jacob D. Cohen 500,000 Shares and Options for 2 Million More

Reuters
·
Sep 13

Mangoceuticals Inc. Secures $1.1M Through Sale of 709,677 Shares to Accredited Investors

Reuters
·
Sep 03

Mangoceuticals Q2 EPS $(0.57) Up From $(1.35) YoY, Sales $168.109K Up From $163.163K YoY

Benzinga
·
Aug 15

BRIEF-Mangoceuticals Inc - On July 30, Co Terminates Agreement With Navy Wharf - SEC Filing

Reuters
·
Aug 04

Mangoceuticals Inc - Navy Wharf Cancels All Navy Shares - SEC Filing

THOMSON REUTERS
·
Aug 04

Mangoceuticals Inc. Announces Issuance of 198,000 Shares from Warrant Exercise and Cancellation of 1,000,000 Shares in Rescission Agreement with Navy Wharf

Reuters
·
Aug 04

Mangoceuticals Inc. Amends Bylaws to Establish Series B Preferred Stock

Reuters
·
Jul 10

Mangoceuticals Inc. Announces Resignation of President and Board Member Antonios "Tony" Isaac, Effective June 2025

Reuters
·
Jul 04